A new hypothesis to explain disease dominance

被引:1
作者
Juvik, Brian [1 ,2 ]
Falcucci, Lara [1 ,2 ]
Lundegaard, Pia R. [3 ]
Stainier, Didier Y. R. [1 ,2 ,4 ]
机构
[1] Max Planck Inst Heart & Lung Res, Dept Dev Genet, D-61231 Bad Nauheim, Hessen, Germany
[2] German Ctr Cardiovasc Res DZHK, Partner Site Rhine Main, D-61231 Bad Nauheim, Hessen, Germany
[3] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark
[4] Excellence Cluster Cardiopulm Inst CPI, Giessen, Germany
基金
欧洲研究理事会;
关键词
HYPERTROPHIC CARDIOMYOPATHY; FRONTOTEMPORAL DEMENTIA; BRUGADA SYNDROME; MUTATIONS; PROGRANULIN; PHENOTYPE; VARIANTS; SEVERITY; GENETICS; GENES;
D O I
10.1016/j.tig.2024.11.009
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The onset and progression of dominant diseases are thought to result haploinsufficiency or dominant negative effects. Here, we propose transcriptional adaptation (TA), a newly identified response to mRNA decay, as an additional cause of some dominant diseases. TA modulates the expression of so-called adapting genes, likely via mRNA decay products, resulting in genetic compensation or a worsening of the phenotype. Recent studies have challenged the concepts of haploinsufficiency or poison proteins as the mechanisms underlying certain dominant diseases, including Brugada syndrome, hypertrophic cardiomyopathy, and frontotemporal lobar degeneration. We hypothesize that for and other dominant diseases, when the underlying mutation leads to decay, the phenotype is due at least partly to the dysregulation of gene expression via TA.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 65 条
  • [1] Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension
    Austin, Eric D.
    Phillips, John A.
    Cogan, Joy D.
    Hamid, Rizwan
    Yu, Chang
    Stanton, Krista C.
    Phillips, Charles A.
    Wheeler, Lisa A.
    Robbins, Ivan M.
    Newman, John H.
    Loyd, James E.
    [J]. RESPIRATORY RESEARCH, 2009, 10
  • [2] Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
    Baker, Matt
    Mackenzie, Ian R.
    Pickering-Brown, Stuart M.
    Gass, Jennifer
    Rademakers, Rosa
    Lindholm, Caroline
    Snowden, Julie
    Adamson, Jennifer
    Sadovnick, A. Dessa
    Rollinson, Sara
    Cannon, Ashley
    Dwosh, Emily
    Neary, David
    Melquist, Stacey
    Richardson, Anna
    Dickson, Dennis
    Berger, Zdenek
    Eriksen, Jason
    Robinson, Todd
    Zehr, Cynthia
    Dickey, Chad A.
    Crook, Richard
    McGowan, Eileen
    Mann, David
    Boeve, Bradley
    Feldman, Howard
    Hutton, Mike
    [J]. NATURE, 2006, 442 (7105) : 916 - 919
  • [3] Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy
    Barefield, David
    Kumar, Mohit
    de Tombe, Pieter P.
    Sadayappan, Sakthivel
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2014, 306 (06): : H807 - H815
  • [4] Is haploinsufficiency a sufficient mechanism for MYBPC3 truncating mutations?
    Barefield, David Y.
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 2023, 155 (04)
  • [5] Human gene essentiality
    Bartha, Istvan
    di Iulio, Julia
    Venter, J. Craig
    Telenti, Amalio
    [J]. NATURE REVIEWS GENETICS, 2018, 19 (01) : 51 - 62
  • [6] The granulin gene family: from cancer to dementia
    Bateman, Andrew
    Bennett, Hugh P. J.
    [J]. BIOESSAYS, 2009, 31 (11) : 1245 - 1254
  • [7] Presenilin clinical mutations can affect γ-secretase activity by different mechanisms
    Bentahir, M
    Nyabi, O
    Verhamme, J
    Tolia, A
    Horré, K
    Wiltfang, J
    Esselmann, H
    De Strooper, B
    [J]. JOURNAL OF NEUROCHEMISTRY, 2006, 96 (03) : 732 - 742
  • [8] Bianchi MT, 2002, J NEUROSCI, V22, P5321
  • [9] RIGHT BUNDLE-BRANCH BLOCK, PERSISTENT ST SEGMENT ELEVATION AND SUDDEN CARDIAC DEATH - A DISTINCT CLINICAL AND ELECTROCARDIOGRAPHIC SYNDROME - A MULTICENTER REPORT
    BRUGADA, P
    BRUGADA, J
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (06) : 1391 - 1396
  • [10] Considerations for reporting variants in novel candidate genes identified fi ed during clinical genomic testing
    Chong, Jessica X.
    Berger, Seth I.
    Baxter, Samantha
    Smith, Erica
    Xiao, Changrui
    Calame, Daniel G.
    Hawley, Megan H.
    Rivera-Munoz, E. Andres
    DiTroia, Stephanie
    Bamshad, Michael J.
    Rehm, Heidi L.
    [J]. GENETICS IN MEDICINE, 2024, 26 (10)